EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Calcineurin Inhibitor–Free, mTOR‐Based Immunosuppression in Chimeric Antigen Receptor T‐Cell Therapy for Post‐Transplant Lymphoproliferative Disorder

Maria Mappoura, Yara Hajj Younes, Sisi Wang, Kadiatou Baldet, Carmen De Ramon Ortiz, Sarah Morin, Stavroula Marouridi-Levrat, Amandine Pradier, Astrid Melotti, Pragallabh Purwar, Chiara Bernardi, Liza Ho und 10 weitere

eJHaem · 2026-12 · 7 (6)

DOI: 10.1002/jha2.70437 ↗

Kurz gefasst

Fachartikel in der Zeitschrift eJHaem, online erschienen am 28.10.2026. Verfasst von Maria Mappoura und 21 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology Department of Oncology Geneva University Hospitals Geneva Switzerland. Die Arbeit nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Relapsed/refractory post‐transplant lymphoproliferative disorder (PTLD) remains a challenging complication after solid organ transplantation (SOT), requiring complex balancing of immune‐suppressive therapy (IST) and lymphoma‐directed therapies.

Methods

We report the case of a 40‐year‐old female kidney‐pancreas transplant recipient with relapsing monomorphic PTLD treated with CD19‐chimeric antigen receptor (CAR) T cells therapy (axicabtagene ciloleucel).

Results

Tacrolimus discontinuation and immunosuppression with everolimus and corticosteroids permitted robust CAR T‐cell expansion, complete lymphoma remission, and preservation of graft function. In vitro studies showed that tacrolimus inhibited CAR T‐cell function, while everolimus preserved it, supporting the use of mTOR‐based, calcineurin‐inhibitor‐free IST during CAR T‐cell therapy in SOT recipients. Conclusion mTOR‐based, calcineurin inhibitor–free immunosuppression can preserve CAR T‐cell function and enable effective therapy in SOT recipients with PTLD.

Schlagwörter

Stichwörter der Autor:innen

calcineurin inhibitorchimeric antigen receptor T‐cell (CAR‐T)everolimusimmunosuppressionpost‐transplant lymphoproliferative disorder (PTLD)solid organ transplantationtacrolimus

Autor:innen und Institutionen

  • Division of Hematology Department of Oncology Geneva University Hospitals Geneva Switzerland.
  • Translational Research Center For Oncohematology Department of Medicine Faculty of Medicine University of Geneva Geneva Switzerland.
  • Department of Pathology and Immunology Faculty of Medicine University of Geneva Geneva Switzerland.
  • Nephrology and Hypertension Division Department of Medicine Geneva University Hospitals Geneva Switzerland.
  • Division of Clinical Pathology Geneva University Hospital Geneva Switzerland.
  • Institute of Oncology Research Faculty of Biomedical Sciences Università Della Svizzera Italiana Bellinzona Switzerland.

Zitieren

APA

Mappoura, M., Hajj Younes, Y., Wang, S., Baldet, K., De Ramon Ortiz, C., Morin, S., Marouridi-Levrat, S., Pradier, A., Melotti, A., Purwar, P., Bernardi, C., Ho, L., Egervari, K., Ducreux, J., Longval, T., Bertoni, F., Chalandon, Y., Haidar, F., de Seigneux, S., …, & Simonetta, F. (2026). Calcineurin Inhibitor–Free, mTOR‐Based Immunosuppression in Chimeric Antigen Receptor T‐Cell Therapy for Post‐Transplant Lymphoproliferative Disorder. eJHaem, 7(6). https://doi.org/10.1002/jha2.70437

Vancouver

Mappoura M, Hajj Younes Y, Wang S, Baldet K, De Ramon Ortiz C, Morin S, et al. Calcineurin Inhibitor–Free, mTOR‐Based Immunosuppression in Chimeric Antigen Receptor T‐Cell Therapy for Post‐Transplant Lymphoproliferative Disorder. eJHaem. 2026;7(6). doi:10.1002/jha2.70437

BibTeX
@article{Mappoura2026,
  author = {Mappoura, Maria and Hajj Younes, Yara and Wang, Sisi and Baldet, Kadiatou and De Ramon Ortiz, Carmen and Morin, Sarah and Marouridi-Levrat, Stavroula and Pradier, Amandine and Melotti, Astrid and Purwar, Pragallabh and Bernardi, Chiara and Ho, Liza and Egervari, Kristof and Ducreux, Julie and Longval, Thomas and Bertoni, Francesco and Chalandon, Yves and Haidar, Fadi and de Seigneux, Sophie and Villard, Jean and Olivier, Valérie and Simonetta, Federico},
  title = {Calcineurin Inhibitor–Free, mTOR‐Based Immunosuppression in Chimeric Antigen Receptor T‐Cell Therapy for Post‐Transplant Lymphoproliferative Disorder},
  journal = {eJHaem},
  year = {2026},
  volume = {7},
  number = {6},
  doi = {10.1002/jha2.70437}
}
Kostenlos starten →